NINGBO INNO PHARMCHEM CO.,LTD. is a proud contributor to the global pharmaceutical supply chain, offering essential chemical intermediates. Among these, 2-Chloro-4-amino-6,7-dimethoxyquinazoline (CAS 23680-84-4) stands out due to its significant role in organic synthesis, particularly within the pharmaceutical sector. This compound, characterized by its molecular formula C10H10ClN3O2 and a molecular weight of 239.66, is a key intermediate used in the multi-step synthesis of various pharmaceutical agents. Its chemical structure lends itself to precise reactions, making it a valuable component for drug discovery and development.

The utility of 2-chloro-4-amino-6,7-dimethoxyquinazoline spans across several important therapeutic areas. As a precursor for drugs like prazosin, doxazosin, terazosin, and alfuzosin, it directly contributes to treatments for conditions such as hypertension and urinary outflow obstruction due to benign prostatic hyperplasia. The precise chemical reactions involved in these synthesis pathways often require intermediates with high purity and specific functional groups, characteristics that 2-chloro-4-amino-6,7-dimethoxyquinazoline reliably possesses. The market for these alpha-blocker drugs ensures a consistent demand for this intermediate, highlighting its commercial importance.

Understanding the synthesis of this compound is crucial for manufacturers aiming for cost-effectiveness and quality. While specific proprietary synthesis routes exist, general methods often involve cyclization reactions and the introduction of chloro and amino substituents onto a dimethoxyquinazoline core. The purity of the final intermediate, typically above 99.5%, is paramount. This high level of purity directly influences the yield and quality of the subsequent API, reducing the need for extensive purification steps later in the process, which can drive up production costs and time. For businesses looking to buy this product, partnering with reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is essential for ensuring product integrity.

Beyond its established applications, the unique quinazoline structure of 2-chloro-4-amino-6,7-dimethoxyquinazoline makes it an attractive building block for research into novel pharmaceutical agents. Its reactivity profile allows chemists to further functionalize the molecule, potentially leading to new drug candidates with improved pharmacological properties. The exploration of quinazoline derivatives in drug discovery is an active field, with potential applications extending beyond alpha-blockers into other therapeutic categories. The availability of this intermediate at competitive prices facilitates such innovative research and development efforts.

In summary, 2-chloro-4-amino-6,7-dimethoxyquinazoline is far more than just another chemical compound; it is a vital cog in the machinery of modern pharmaceutical manufacturing and drug discovery. Its role in the synthesis of essential medicines, coupled with its chemical versatility, cements its status as a key pharmaceutical intermediate. Companies committed to advancing healthcare rely on the consistent quality and availability of such foundational materials, and NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting these critical needs.